ArticleJournal of blood medicine2026
Non-Traumatic Fat Embolism Syndrome in Sickle Cell Disease Complicated by Bone Marrow Necrosis Successfully Treated with Therapeutic Plasma Exchange: A Case Report.
Article in Journal of blood medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-traumatic fat embolism syndrome (NT-FES) is a rare but frequently fatal complication of sickle cell disease (SCD) that is often associated with bone marrow necrosis. A delayed diagnosis or lack of standard criteria leads to a higher mortality rate. Firstline therapy in NT-FES is red cell exchange transfusion (RCE); however, therapeutic plasma exchange (TPE) is considered to be an adjunct or potential alternative in recent times. Case Presentation: We report a case of a middle-aged male with HbSS sickle cell disease and α-thalassemia trait who presented with a vaso-occlusive crisis, which led to severe multiorgan failure, including acute respiratory failure, seizures, acute kidney injury requiring continuous renal replacement therapy, acute hepatic injury, and cardiac ischemia. The laboratory reports showed remarkable hemolysis, hyperferritinemia and cytopenia. The clinical symptoms were consistent with NT-FES secondary to bone marrow necrosis. Intervention: The patient went through three sessions of therapeutic plasma exchange along with supportive therapy due to alloimmunization and unavailability of compatible RCE. Outcome: The patient showed remarkable clinical improvement, which included recovery of consciousness, resolution of seizures, stabilization of hemolysis markers, and normalization of renal and hepatic parameters. Conclusion: This case demonstrates NT-FES as a critical and underrecognized complication of sickle cell disease. Immediate intervention is necessary to avoid mortality; TPE therapy presents itself as a potential life‑saving intervention in cases with immuno-incompatibility and delayed RCE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.